|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.08 EUR | -0.79% |
|
-3.50% | +5.08% |
| 07-22 | Eckert & Ziegler: BaFin reviews 2024 financial statements over Pentixapharm spin-off | DP |
| 07-22 | Eckert & Ziegler next in BaFin's sights, shares rebound | DP |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 43.65 | 51.8 | 51.8 |
| Spread/Res. | -5.27% | -20.17% | -20.17% |
| Spread/Supp. | +2.61% | +13.76% | +27.23% |
| Support | 40.3 | 36.35 | 32.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DMP Stock
- Charts Dermapharm Holding SE
Select your edition
All financial news and data tailored to specific country editions
